• Belshe, Robert. 2009. Implications of the emergence of a novel H1 influenza virus. N Engl J Med. 360: 2667-2668.

  • Bragstad K, Nielsen L P, Fomsgaard A. The evolution of human influenza A viruses from 1999 to 2006: A complete genome study[J]. Virol J, 2008, 5(40): 1-19.

  • CDC. 2009. Realtime RTPCR (rRTPCR) Protocol for Detection and Characterization of Swine Influenza (version2009). http://www.who.int/csr/restheces/publications/swineflu/realtimeptpcr/en/index.html.

  • Cinatl J Jr, Michaelis M, Doerr H W, et al. 2007. The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants. Med Microbiol Immunol, 196: 181-190.

  • Deyde V M, Sheu T G, Trujillo A A. Detection of Molecular Markers of Drug Resistance in 2009 Pandemic Influenza A (H1N1) Viruses by Pyrosequencing[J]. Antimicrob Agents Ch, 2010, 54(3): 1102-1110. doi: 10.1128/AAC.01417-09

  • Dunham E J, Dugan V G, Kaser E K. Different Evolutionary Trajectories of European Avian-Like and Classical Swine H1N1 Influenza A Viruses[J]. J Virol, 2009, 83(11): 5485-5494. doi: 10.1128/JVI.02565-08

  • European Centre for Disease Prevention and Control special report. The 2009 A(H1N1) pandemic in Europe. http://www.ecdc.europa.eu/en/publications/Publications/101108_SPR_pandemic_experience.pdf.

  • Galwankar S, Clem A. Swine influenza A (H1N1) strikes a potential for global disaster[J]. J Emerg Trauma Shock, 2009, (): 99-105.

  • Mould J A, Drury J E, Frings S M. Permeation and activation of the M2 ion channel of influenza A virus[J]. J Biol Chem, 2000, 275(): 31038-31050. doi: 10.1074/jbc.M003663200

  • Nelson M, Spiro D, Wentworth D, et al. 2009. The early diversification of influenza A/H1N1pdm. PLoS Curr, RRN1126.

  • Puzelli S, Facchini M, Di Martino A, et al. 2011. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic. Antiviral Res. 90: 205-212.

  • Shinde V, Bridges C B, Uyeki T M, et al. 2009. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005–2009. N Engl J Med. 360: 2616-2625.

  • Subbarao E K, London W, Murphy B R. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range[J]. J Virol, 1993, 67(): 1761-1764.

  • Wetherall N T, Trivedi T, Zeller J. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network[J]. J Clin Microbiol, 2003, (): 742-750.

  • World Health Organization (WHO). Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus[J]. Wkly Epidemiol, 2010, 85(): 37-48.

  • Yang J R, Lin Y C, Huang Y P. Reassortment and Mutations Associated with Emergence and Spread of Oseltamivir-Resistant Seasonal Influenza A/H1N1 Viruses in 2005-2009[J]. PLoS ONE, 2011, 6(3): e18177-. doi: 10.1371/journal.pone.0018177